Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Anti-Thyroid Drugs Market Growth Potential: How Will Market Size Shift Through 2030?
The market size for anti-thyroid drugs has experienced a modest expansion in recent years. This sector is projected to grow from $2.49 billion in 2025 to $2.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.0%. The historical increase can be ascribed to several factors, including the high prevalence of hyperthyroidism, the accessibility of oral therapies, widespread diagnostic testing practices, established endocrine care systems, and their utilization in radiation protection.
The anti-thyroid drugs market size is projected to experience consistent expansion in the coming years. By 2030, it is anticipated to reach a value of $2.85 billion, exhibiting a compound annual growth rate (CAGR) of 2.9%. This projected growth during the forecast period stems from factors such as an increase in autoimmune thyroid diseases, enhanced screening initiatives, greater access to healthcare, advancements in thyroid regulation treatments, and an aging demographic. Key developments anticipated during this period include a rise in the diagnosis of thyroid disorders, increased adoption of thionamide-based medications, broader availability of outpatient thyroid care, more frequent monitoring of hormone levels, and enhancements in drug safety profiles.
Get A Free Sample Report With In-Depth Market Insights:
Anti-Thyroid Drugs Market Growth Factors Behind Sustained Expansion
The rising incidence of thyroid cancer is anticipated to propel the expansion of the anti-thyroid drugs market in the future. Thyroid cancer is an ailment affecting the thyroid gland, located near the throat’s base, responsible for producing hormones that regulate body temperature, heart rate, blood pressure, and weight. This increased occurrence of thyroid cancer largely stems from enhanced exposure to medical radiation and environmental carcinogens. Anti-thyroid drugs aid in identifying thyroid cancer through early detection, which can lead to better treatment outcomes. For example, in August 2023, the American Society of Clinical Oncology, a US-based community for oncologists and surgeons, reported that in the United States, approximately 43,720 adults (comprising 12,540 men and 31,180 women) received a thyroid cancer diagnosis in 2023, with an estimated 2,120 deaths (970 men and 1,150 women) from the condition predicted for the same year. Consequently, the growing prevalence of thyroid cancer is driving the expansion of the anti-thyroid drugs market.
Anti-Thyroid Drugs Market Segment Analysis And Revenue Potential
The anti-thyroid drugs market covered in this report is segmented –
1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)
2) By Route of Administration: Oral, Intravenous, Other Route Of Administration
3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels
Subsegments:
1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil
2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution
Anti-Thyroid Drugs Market Industry Trends Fueling Future Revenue Growth
Leading companies within the anti-thyroid drugs market are concentrating on developing innovative products, including monoclonal antibodies, with the goal of improving patient outcomes, mitigating adverse effects, and strengthening their competitive position. Monoclonal antibodies are laboratory-engineered proteins designed to accurately target specific molecules in the body, thereby facilitating more effective disease treatment. For instance, in March 2025, Innovent Biologics, Inc., a biotechnology company based in China, announced that SYCUME, an anti-IGF-1R monoclonal antibody, received approval from China’s National Medical Products Administration (NMPA) for the treatment of thyroid eye disease (TED). SYCUME marks the first drug of its kind approved in China and the second worldwide, presenting a novel, effective treatment option that substantially reduces proptosis and inflammation while elevating patients’ quality of life. This approval is founded on positive clinical trial results that demonstrated SYCUME’s capability to address the unmet needs of TED patients, offering a safer, more accessible alternative to current therapies.
Anti-Thyroid Drugs Market Key Players Shaping Industry Direction
Major companies operating in the anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.
View The Full Anti-Thyroid Drugs Market Report:
Anti-Thyroid Drugs Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the anti-thyroid drugs market in 2025. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
